Virander S Chauhan Selected Research

Merozoite Surface Protein 1 (MSA1)

3/2015	Malaria and HIV infection in Mozambican pregnant women are associated with reduced transfer of antimalarial antibodies to their newborns.
1/2015	Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
1/2015	Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
2/2012	Kinetics of humoral and memory B cell response induced by the Plasmodium falciparum 19-kilodalton merozoite surface protein 1 in mice.
2/2012	Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
8/2010	Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli.
5/2010	Antibody and cellular immune responses to Plasmodium falciparum histidine-rich protein II in malaria-exposed individuals in Orissa, India.
8/2006	Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by Azurin.
3/2004	Inter-allelic recombination in the Plasmodium vivax merozoite surface protein 1 gene among Indian and Colombian isolates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virander S Chauhan Research Topics

Disease

46	Malaria 05/2022 - 04/2002
12	Infections 05/2022 - 05/2005
3	Neoplasms (Cancer) 01/2018 - 01/2012
3	HIV Infections (HIV Infection) 03/2015 - 02/2012
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2015 - 08/2006
3	Decompression Sickness (Bends) 12/2011 - 08/2007
3	Rupture 05/2008 - 06/2002
2	Parasitemia 05/2022 - 08/2006
2	Vivax Malaria 05/2022 - 09/2006
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Hepatitis B 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2014
1	Melanoma (Melanoma, Malignant) 01/2012
1	Parasitic Diseases (Parasitic Disease) 05/2008
1	AIDS-Related Complex (ARC) 04/2007
1	Coinfection 08/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2006

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 05/2022 - 03/2004
15	Proteins (Proteins, Gene)FDA Link 04/2014 - 06/2002
13	AntigensIBA 01/2018 - 04/2002
10	AntibodiesIBA 01/2018 - 09/2009
9	Merozoite Surface Protein 1 (MSA1)IBA 03/2015 - 03/2004
8	Immunoglobulin G (IgG)IBA 01/2018 - 09/2009
8	Peptides (Polypeptides)IBA 04/2014 - 04/2002
6	Antimalarials (Antimalarial Agents)IBA 03/2015 - 09/2003
6	Cysteine Proteases (Cysteine Protease)IBA 06/2008 - 09/2002
5	Peptide Hydrolases (Proteases)FDA Link 10/2013 - 06/2002
4	Pharmaceutical PreparationsIBA 12/2013 - 04/2009
4	falcipain 2IBA 06/2008 - 04/2004
3	DipeptidesIBA 01/2018 - 01/2012
3	Recombinant ProteinsIBA 01/2015 - 05/2005
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 05/2022 - 01/2018
2	Immunoglobulin M (IgM)IBA 01/2018 - 01/2017
2	phenyldehydroalanineIBA 12/2013 - 01/2012
2	Surface Antigens (Surface Antigen)IBA 06/2013 - 04/2011
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 06/2013 - 04/2011
2	Histidine (L-Histidine)FDA Link 05/2010 - 12/2006
2	EnzymesIBA 09/2009 - 03/2007
2	hemozoinIBA 01/2005 - 09/2003
2	Heme (Haem)IBA 01/2005 - 09/2003
2	LipidsIBA 09/2003 - 05/2003
1	TOR Serine-Threonine KinasesIBA 01/2018
1	LigandsIBA 01/2017
1	Antimicrobial PeptidesIBA 04/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2013
1	SubtilisinIBA 10/2013
1	P 11 (P-11)IBA 02/2012
1	insulin receptor-related receptor (IRR)IBA 02/2012
1	Biological ProductsIBA 01/2012
1	Plasmodium falciparum serine repeat antigen 5IBA 01/2012
1	PeptidomimeticsIBA 01/2012
1	CurcuminIBA 01/2012
1	Amino Acids FDA Link 01/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2011
1	LectinsIBA 02/2011
1	T-box transcription factor TBX21IBA 02/2011
1	Granzymes (Granzyme)IBA 02/2011
1	L-SelectinIBA 02/2011
1	ATP-Dependent ProteasesIBA 08/2010
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2010
1	ImmunosorbentsIBA 09/2009
1	HMGB1 Protein (HMG1)IBA 06/2008
1	Hemoglobins (Hemoglobin)IBA 05/2008
1	CytokinesIBA 03/2007
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	AzurinIBA 08/2006
1	falcipainIBA 11/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2005
1	Serine (L-Serine)FDA Link 11/2005
1	Small Interfering RNA (siRNA)IBA 11/2005
1	beta Karyopherins (Importin-beta)IBA 05/2005
1	type I signal peptidase (signal peptidase)IBA 01/2005
1	Chloroquine (Aralen)FDA LinkGeneric 09/2003
1	artemisinin (artemisinine)IBA 09/2003
1	histidine-rich proteinsIBA 09/2003
1	Biotin (Vitamin H)FDA Link 05/2003
1	StreptavidinIBA 05/2003
1	Human Serum Albumin FDA LinkGeneric 05/2003
1	NucleotidesIBA 09/2002
1	Double-Stranded RNA (RNA, Double Stranded)IBA 09/2002
1	Plasmodium falciparum erythrocyte membrane protein 1IBA 04/2002

Therapy/Procedure

2	Therapeutics 12/2013 - 01/2012
1	Intravenous Injections 01/2018
1	Phytotherapy (Herbal Therapy) 01/2012